Emergence of YMDD motif mutant of hepatitis B virus during short-term lamivudine therapy in South Korea
- 1 July 2001
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 35 (1) , 92-98
- https://doi.org/10.1016/s0168-8278(01)00065-4
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Selection of Multiresistant Hepatitis B Virus during Sequential Nucleoside‐Analogue TherapyThe Journal of Infectious Diseases, 2000
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapyHepatology, 1999
- Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapyHepatology, 1999
- Identification and characterization of mutations in hepatitis B virus resistant to lamivudineHepatology, 1998
- Lamivudine resistance inimmunocompetent chronic hepatitis BJournal of Hepatology, 1997
- Phosphatidyl-2′,3′-dideoxy-3′-thiacytidine: synthesis and antiviral activity in hepatitis B- and HIV-1-infected cellsAntiviral Research, 1995
- Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)The Journal of Infectious Diseases, 1995
- Anti-Human Immunodeficiency Virus and Anti-Hepatitis-B Virus Activities and Toxicities of the Enantiomers of 2'-Deoxy-3'-oxa-4'-thiocytidine and Their 5-Fluoro Analogs in VitroJournal of Medicinal Chemistry, 1995
- Avoiding false positives with PCRNature, 1989